Literature DB >> 18549942

Isolated microcytic anemia disclosing a unicentric Castleman disease: The interleukin-6/hepcidin pathway?

Stéphane Vinzio1, Laetitia Ciarloni, Jean-Louis Schlienger, Serge Rohr, Agnès Méchine, Bernard Goichot.   

Abstract

Castleman disease (CD) is a rare lymphoproliferative disorder of uncertain origin. Anemia is commonly reported and is related to an inflammatory mechanism. Occasionally an autoimmune hemolytic anemia appears as the leading clinical feature. Three histological types have been differentiated, a hyaline-vascular type (HV), a plasma cell type (PC), and a mixed type. Clinically CD is separated into unicentric (localized) or multicentric (generalized) forms. The former is most frequently of HV type (80-90%), affecting a single lymph node. The PC type is encountered in 10-20% of the unicentric CD and in almost all of the multicentric cases. Numerous systemic manifestations have been described usually associated with PC type. An isolated and markedly microcytic anemia revealing a unicentric CD has never been reported in English literature. Recent data concerning iron metabolism, interleukin-6 and hepcidin provide interesting clues to understand the particular microcytic anemia of CD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18549942     DOI: 10.1016/j.ejim.2007.09.006

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  9 in total

Review 1.  Castleman's disease: from basic mechanisms to molecular therapeutics.

Authors:  Hazem E El-Osta; Razelle Kurzrock
Journal:  Oncologist       Date:  2011-03-25

2.  A retrospective study of 34 patients with unicentric and multicentric Castleman's disease: Experience from a single institution.

Authors:  Jin-Peng Jiang; Xiao-Fei Shen; Jun-Feng Du; Wen-Xian Guan
Journal:  Oncol Lett       Date:  2017-12-14       Impact factor: 2.967

3.  Anemia resolved by thoracoscopic resection of a mediastinal mass: a case report of unicentric Castleman's disease.

Authors:  Jong Hui Suh; Sook Hee Hong; Seong Cheol Jeong; Chan Beom Park; Kuk Bin Choi; Ok Ran Shin; Si Young Choi
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

Review 4.  Iron sequestration and anemia of inflammation.

Authors:  Tomas Ganz; Elizabeta Nemeth
Journal:  Semin Hematol       Date:  2009-10       Impact factor: 3.851

Review 5.  Multicentric Castleman's disease: a challenging diagnosis.

Authors:  Györgyi Műzes; Ferenc Sipos; Judit Csomor; Lídia Sréter
Journal:  Pathol Oncol Res       Date:  2013-03-21       Impact factor: 3.201

6.  Iron-Refractory Iron Deficiency Anemia in an 11-year-old Girl.

Authors:  Neeraja Swaminathan; Scott M Lieberman; Sharathkumar Bhagavathi; Anjali Sharathkumar
Journal:  Pediatr Rev       Date:  2021-07

7.  A Rare Cause of Unexplained Refractory Iron Deficiency Anemia: Unicentric Plasma-Cell Type Castleman's Disease.

Authors:  Sevgi Kalayoğlu Beşışık; İpek Yönal Hindilerden; Fehmi Hindilerden; İbrahim Öner Doğan; Fatih Beşışık
Journal:  Turk J Haematol       Date:  2016-04-22       Impact factor: 1.831

Review 8.  Dysregulated iron metabolism in polycythemia vera: etiology and consequences.

Authors:  Yelena Z Ginzburg; Maria Feola; Eran Zimran; Judit Varkonyi; Tomas Ganz; Ronald Hoffman
Journal:  Leukemia       Date:  2018-07-24       Impact factor: 11.528

9.  Castleman disease.

Authors:  Ibrahiem Saeed-Abdul-Rahman; Ali M Al-Amri
Journal:  Korean J Hematol       Date:  2012-09-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.